Intestinal bacteria that can boost bravery or trigger multiple sclerosis: An increasing body of research results confirms the importance of the “gut-brain axis” for neurology and indicates that the triggers for a number of neurological diseases may be located in the digestive tract.

It's widely accepted that Multiple Sclerosis (MS) is an autoimmune disease. The cause of MS is unknown and there is no cure. But some maverick doctors contend that MS is triggered by an infection which can be treated. It's believed that a common bacterium, http://www.abc.net.au/catalyst/ Chlamydia pneumoniae can infect blood vessels in the brain and spinal cord and ultimately lead to nerve damage. Maryanne Demasi meets the doctors who are at odds with neurologists in proposing that an early diagnosis of MS could be cured with something as simple as antibiotics.

It may come as a surprise to some, especially those with conventional medical training, but the default state of the body is one of ceaseless regeneration. Without the flame-like persistence of continual cell turnover within the body - life and death ceaselessly intertwined - the miracle of the human body would not exist

MS patients to consider increasing their consumption of prebiotic foods as a method of achieving immune balance.

Some studies have suggested that minerals such as zinc and iron may play a role in how multiple sclerosis (MS) progresses, once people have been diagnosed with it. But little was known about whether zinc, iron and other minerals play a role in the development of the disease. A new study shows no link between dietary intake of several minerals and whether people later develop MS.

Multiple sclerosis (MS) is an immune-mediated disease, the etiology of which involves both genetic and environmental factors. The exact nature of the environmental factors responsible for predisposition to MS remains elusive; however, it’s hypothesized that gastrointestinal microbiota might play an important role in pathogenesis of MS. Therefore, this study was designed to investigate whether gut microbiota are altered in MS by comparing the fecal microbiota in relapsing remitting MS (RRMS) (n = 31) patients to that of age- and gender-matched healthy controls (n = 36). Phylotype profiles of the gut microbial populations were generated using hypervariable tag sequencing of the V3–V5 region of the 16S ribosomal RNA gene. Detailed fecal microbiome analyses revealed that MS patients had distinct microbial community profile compared to healthy controls. We observed an increased abundance of Psuedomonas, Mycoplana, Haemophilus, Blautia, and Dorea genera in MS patients, whereas control group showed increased abundance of Parabacteroides, Adlercreutzia and Prevotella genera. Thus our study is consistent with the hypothesis that MS patients have gut microbial dysbiosis and further study is needed to better understand their role in the etiopathogenesis of MS.

Dr. Terry Wahls was given a diagnosis of MS and told she'd have to spend the rest of her life in a wheelchair. After radically transforming her diet, her outlook, and her medical care, she is now able to walk and ride a bicycle. Here's how she defied disease and what you can learn from her experience. ABOUT mbg: mindbodygreen. One word. Here you’ll find a 360-degree approach to wellness that weaves the mental, physical, spiritual, emotional, and environmental aspects of well-being together, because we believe that these pillars of health are all interconnected. Our values: - Science & Research - Committed to the whole you - Quality Sourced You can check us out here: https://www.mindbodygreen.com/ Follow us on Social - @mindbodygreen Instagram: https://www.instagram.com/mindbodygreen/ Facebook: https://www.facebook.com/mindbodygreen/ Twitter: https://twitter.com/mindbodygreen Pinterest: https://www.pinterest.com/mindbodygreen/

A crucial development has been made in the treatment of Multiple Sclerosis (MS). A research team has demonstrated in an animal model that, following treatment with a specially synthesized plant peptide (cyclotide), there is no further progression of the usual clinical signs of multiple sclerosis.

In long-lived animals, renewed but thin myelin sheaths are enough to restore the impaired nervous system and can do so for years after the onset of disease, scientists have discovered.

Mapping of a certain group of cells, known as oligodendrocytes, in the central nervous system of a mouse model of multiple sclerosis (MS), shows that they might have a significant role in the development of the disease. The discovery can lead to new therapies targeted at other areas than just the immune system.

In multiple sclerosis, a defective response of the body's own immune system leads to brain tissue damage. Gastrointestinal microbiota could play a far greater role in the pathogenesis of the disease than previously assumed.

DuckDuckGo. Privacy, Simplified.

Many times there are extremely positive preliminary results with a natural product improving very serious health condition and there are no follow up studies. In 2005, a clinical trial indicated that a common dietary supplement can produce meaningful improvements in multiple sclerosis. Since this initial study there has been considerable additional studies that also demonstrate dietary supplementation with this compound is capable of making a positive clinical impact

Multiple sclerosis, or MS, is an autoimmune condition, and this is a disease that actually has…

Researchers have found definite evidence of remyelination after taking Clemastine, and the improvement persisted when the drug was stopped.

Multiple sclerosis (MS) is believed to be one of the most widespread and disabling neurological conditions in the world, with an estimated 2.3 million people suffering from the condition worldwide. The latest statistics estimate that there are currently 400,000 individuals suffering from MS in the US and a further 100,000 individuals in the UK

Researchers have found that a widely prescribed drug for multiple sclerosis (MS) is associated with longer survival for patients.

People suffering from multiple sclerosis have relied on a drug called interferon-beta to prevent flare-ups of the disease and avoid its crippling neurological symptoms. But interferon-beta treatment has its downsides: the drug is expensive, it can cause flu-like side-effects, and for up to half of patients, it simply doesn't work. New research may point to alternative treatments for MS, report scientists.

Dr Wahls explains clearly the reasons why we should all be eating more raw foods, leafy green vegetables and fruits. You will be inspired by this amazing story of self healing. At http://www.theallergymenu.com we love to share stories like these, real people making a difference and leading the way in health and wellbeing.

The antidepressant clomipramine may also alleviate symptoms of multiple sclerosis, specifically in its progressive form, i.e. when it occurs without relapses or remissions. As yet, drugs for this type of MS have been virtually non-existent. Researchers screened 1,040 generic therapeutics and, based on preclinical studies, identified one that is suitable for the treatment of multiple sclerosis.

Myelin is a structure that protects neurons. Certain lifestyle and dietary factors may increase myelination; learn more about it here.

New research supports the idea that multiple sclerosis (MS), which has widely varying symptoms and progression in different patients, is nonetheless a single disease with common underlying mechanisms.

Dr. Saray Stancic's new documentary, Code Blue, is both a powerful indictment of health care today and a call to action. Read our interview with her here.